ANACLE (08353) released its interim performance with a net profit attributable to shareholders of 89.853 million Singapore dollars, turning losses into gains year-on-year.
Angcore Systems (08353) announced its performance for the six-month period ending on November 30, 2024. The group's revenue reached 14...
ANACLE (08353) released its performance for the six months ended November 30, 2024, with a group revenue of 14.5049 million Singapore dollars, representing a year-on-year growth of 29.32%. Net profit attributable to shareholders was 8.9853 million Singapore dollars, turning from loss to profit compared to the same period last year, with earnings per share of 0.02 Singapore cents.
Related Articles
Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.
SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.
Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
Guangdong Taienkang Pharmaceutical (301263.SZ): The application for the registration and listing approval of sulfamethoxazole tablets has been accepted.
SoftBank (SFTBY.US) and OpenAI's Japan AI joint venture plan has been reported to be delayed, with new developments expected to be announced in November.
Guotai Haitong: Initiates "buy" rating on BEST PACIFIC (02111) with a target price of HK$4.42.
